Jubilant Pharmova Share Price

Jubilant Pharmova Share Price

NSE: JUBLPHARMA
|
Pharmaceuticals
|
S Cap
₹ 1,005.00
-₹6.95 (-0.69%)
1D
Last updated 16 Sep, 2026, 15:29 IST

Jubilant Pharmova Share Price Today

As of 17 Sep 2026, Jubilant Pharmova share price is ₹1,005.00. The stock opened at ₹1,010.00, compared to its previous close of ₹1,011.95. During today's trading session, Jubilant Pharmova share price moved in the range of ₹977.50 to ₹1,010.00, with an average price of ₹993.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹786.05 and a high of ₹1,184.80. On the performance front, Jubilant Pharmova share price has increased by 19.35% over the last six months and is down 10.52% on a year-on-year basis.

₹977.50
0.69% down today
₹1,010.00
1D LOW
1D HIGH

Jubilant Pharmova Returns Calculator

Circuit
L
H
₹809.60
₹1,214.30
52-week
L
H
₹786.05
₹1,184.80

About Jubilant Pharmova

Jubilant Pharmova Share Price
ISIN
INE700A01033
Sector Market Cap
₹ 16,082.93 Cr

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.

Jubilant Pharmova Financial Highlights

  • Revenue: Jubilant Pharmova reported revenue of ₹8,345.60 crore in FY26 vs ₹7,291.30 crore in FY25. It showed an increase of 14.46% on a yearly basis.
  • Operating Profit: Jubilant Pharmova reported an operating profit of ₹614.10 crore in FY26 vs ₹980.60 crore in FY25. It showed a decrease of 37.38% on a year-on-year basis.
  • Net Profit: Jubilant Pharmova reported a net profit of ₹397.50 crore in FY26 vs ₹836.30 crore in FY25. It showed a decrease of 52.47% on a yearly basis.

Jubilant Pharmova Quarterly Result Highlights

  • Jubilant Pharmova reported revenue of ₹2,249.30 crore in Jun 2026, compared with ₹2,313.70 crore in Mar 2026, representing a decrease of 2.78% on a quarter-on-quarter (QoQ) basis.
  • Jubilant Pharmova reported an operating profit of ₹86.40 crore in Jun 2026, compared with ₹176.00 crore in Mar 2026, representing a decrease of 50.91% on a quarter-on-quarter (QoQ) basis.
  • Jubilant Pharmova reported a profit of ₹56.40 crore in Jun 2026, compared with ₹119.30 crore in Mar 2026, reflecting a decrease of 52.72% on a QoQ basis.
  • The earnings per share (EPS) of Jubilant Pharmova stood at ₹25.15 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
47.68%
FII
15.87%
Other DII
3.40%
Retail and other
24.05%
Mutual funds
8.99%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202516.57%
Dec 202515.96%
Mar 202615.90%
Jun 202615.87%
Mkt Cap Cr
16,082.90
P/E
45.45
P/B
2.25
ROE
5.62%
D/E
0.02
ROCE
6.41%
Div. Yield
0.49%
EPS(TTM)
3.97
Turnover
0.11
EV/EBITDA
14.98
Net Margin
26.88%
Op. Margin
19.43%
ROA
2.26%
Quick Ratio
0.90
Curr. Ratio
0.92
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Jubilant Pharmo outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Jubilant Pharmo appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Jubilant Pharmo earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,40,278.0036.705.3213.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,43,966.0083.5014.5715.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.0921.8225.49%1.6913.85%222.760.70%0.4958.70
Cipla1,09,849.0032.763.1911.27%0.0014.95%423.360.96%0.4543.52
Zydus Lifesciences1,09,626.0024.004.0718.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs1,02,984.0095.2919.6016.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories95,967.4030.032.5111.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma95,794.7025.452.499.25%0.1911.76%394.820.24%0.3841.58
Mankind Pharma94,531.6044.915.7011.74%0.3413.13%396.980.04%0.4449.37
Lupin93,984.1016.864.1723.76%0.0424.88%659.000.88%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Jubilant Pharmova Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹8,279.60₹7,234.50₹6,702.90₹6,281.70
Other Income₹66.00₹56.80₹68.70₹38.30
Total Revenue₹8,345.60₹7,291.30₹6,771.60₹6,320.00
Total Expenses₹7,672.00₹6,669.70₹6,456.30₹6,247.70
Profit Before Tax₹614.10₹980.60₹170.50₹27.80
Tax₹216.60₹144.30₹97.80₹92.70
Profit After Tax₹397.50₹836.30₹72.70-₹64.90
EPS - Basic₹25.15₹52.99₹4.87-₹3.83
EPS - Diluted₹25.08₹52.85₹4.86-₹3.83

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹614.10₹980.60₹170.50₹27.80
Income before WC changes₹1,296.80₹1,198.70₹925.90₹810.70
Change in Assets-₹149.60₹73.50₹197.00₹118.00
Change in Liabilities₹289.00₹38.30₹56.10-₹63.70
Change in WC₹139.40₹111.80₹253.10₹54.30
Cash flow from Operations₹1,226.80₹1,072.10₹971.30₹660.70
Cash flow from Investing-₹1,260.00₹487.70-₹607.90-₹544.40
Cash flow from Financing₹94.90-₹1,452.70-₹432.50-₹156.70
Total Cash Flow₹178.80₹131.90-₹57.50₹30.10
Cash (Start of the year)₹1,088.30₹956.40₹1,013.90₹983.80
Cash (End of the year)₹1,267.10₹1,088.30₹956.40₹1,013.90

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹11,413.40₹9,179.20₹7,672.40₹7,394.30
Current Assets₹4,109.30₹3,577.20₹3,876.10₹3,762.40
Total Assets₹15,522.70₹12,756.40₹11,548.50₹11,156.70
Current Liabilities₹2,538.90₹2,164.60₹1,889.00₹1,772.40
Net Current Asset₹1,570.40₹1,412.60₹1,987.10₹1,990.00
Non-Current Liabilities₹5,888.20₹4,353.20₹4,238.40₹3,992.50
Equity Capital₹7,095.60₹6,238.60₹5,421.10₹5,391.80
Total Equity & Liabilities₹15,522.70₹12,756.40₹11,548.50₹11,156.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹263.50₹231.40₹784.70₹810.10
Other Income₹2.40₹20.20₹103.40₹137.90
Total Revenue₹265.90₹251.60₹888.10₹948.00
Total Expenses₹228.00₹210.20₹846.40₹868.70
Profit Before Tax₹29.20₹41.40₹41.70₹79.30
Tax₹9.30₹19.20₹10.10₹29.40
Profit After Tax₹19.90₹22.20₹31.60₹49.90
EPS - Basic₹3.97₹1.21₹1.99₹3.13
EPS - Diluted₹3.97₹1.21₹1.99₹3.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹33.50₹37.60₹41.70₹79.30
Income before WC changes₹76.30₹116.80₹89.90₹44.10
Change in Assets₹24.50₹24.30₹71.50-₹55.90
Change in Liabilities-₹1.40₹7.00-₹6.00-₹35.90
Change in WC₹23.10₹31.30₹65.50-₹91.80
Cash flow from Operations₹93.60₹135.60₹143.20-₹65.10
Cash flow from Investing₹43.60-₹2.30-₹40.30₹31.10
Cash flow from Financing-₹129.90-₹156.80-₹77.80₹22.50
Total Cash Flow₹7.30-₹23.50₹25.10-₹11.50
Cash (Start of the year)₹12.60₹36.10₹11.00₹22.50
Cash (End of the year)₹10.30₹12.60₹36.10₹11.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,381.80₹2,425.40₹2,451.30₹2,429.60
Current Assets₹50.90₹484.20₹540.60₹578.80
Total Assets₹2,432.70₹2,909.60₹2,991.90₹3,008.40
Current Liabilities₹56.70₹310.30₹315.40₹361.20
Net Current Asset-₹5.80₹173.90₹225.20₹217.60
Non-Current Liabilities₹63.70₹281.20₹302.00₹232.70
Equity Capital₹2,312.30₹2,318.10₹2,374.50₹2,414.50
Total Equity & Liabilities₹2,432.70₹2,909.60₹2,991.90₹3,008.40
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1002.5
1203
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1203
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
66.3
Neutral
ATR (14)
31.49
Neutral
STOCH(9,6)
75.97
Neutral
STOCH RSI (14)
78.14
Neutral
ADX(9)
42.01
Bearish
UO(9)
67.07
Neutral
ROC(12)
13.86
Bullish
WillR(14)
-20.42
Neutral
Period
Simple value
Exponential vaue
5D
1017.36
1004.87
10D
976.75
982.59
20D
931.23
956.22
50D
945.56
945.87
100D
960.77
949.78
Volume trend — traded volume by day
16 Sep1L
15 Sep1L
11 Sep2L
10 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Jubilant Pharmova Share Price
Jubilant Pharmova
Pharmaceuticals
Add Stock
Add Another

Jubilant Pharmova Share Price FAQs

Jubilant Pharmova share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837